54gene provides genetic testing and molecular diagnostics services to patients and physicians in order to expand access to precision medicine in Africa.

54gene is partnering with hospitals and research institutions in African countries; and with pharmaceutical and biotechnology companies to address the challenge of limited diverse genomics data, which may hold the key to medical discoveries and new healthcare solutions.

54gene is backed by investors including Y Combinator, Adjuvant Capital, The Bill and Melinda Gates Foundation, Novartis, Fifty Years Ventures, Better Ventures, KdT Ventures and others. The company raised $15M in a Series A round on Apr 14, 2020. This brings 54gene's total funding to $19.5M to date.